Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Alferon LDO
DRUG
2 trials
Sponsors
AIM ImmunoTech Inc.
Conditions
HIV Infections
Severe Acute Respiratory Syndrome
Phase 2
Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
Completed
NCT00215826
AIM ImmunoTech Inc.
Severe Acute Respiratory Syndrome
Start: 2004-11-30
End: 2006-04-30
Updated: 2013-04-17
A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects
Terminated
NCT00215852
AIM ImmunoTech Inc.
HIV Infections
Start: 2005-07-31
End: 2009-04-30
Updated: 2013-09-04